Medprin Regenerative Medical Technologies Co. Ltd. (301033.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · China · ISIN CNE100004NB8

Price
52.13 CNY
Market cap
3.50 bn CNY
P/E (2025)
30.90
P/S (2025)
9.48
Dividend yield
1.34 %
Net margin
30.67 %
Return on equity (ROE)
14.18 %
Return on assets (ROA)
12.63 %

Medprin Regenerative Medical Technologies Co. Ltd. financials

Fiscal year20242025
Revenue278.44 m CNY368.83 m CNY
Gross profit220.88 m CNY295.91 m CNY
Operating income86.98 m CNY126.94 m CNY
EBIT94.06 m CNY126.19 m CNY
Net income78.85 m CNY113.13 m CNY
Diluted EPS – continuing operations1.19 CNY1.69 CNY

Full history since 2019, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Medprin Regenerative Medical Technologies Co. Ltd.

Medprin Regenerative Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of implantable medical devices in China and internationally. The company offers artificial dura mater patches, craniofacial repair and fixation systems, and absorbable regenerative oxidation for neurosurgery meningeal repair, skull repair fixation and rapid hemostasis, etc. It also offers ReDura, a Synthetic Dural Substitute; NeoDura, a novel dural patch; Recranio, a Cranio-Maxillofacial repair system; and StypCel, an Absorbable Hemostat; Immiseal, a dural sealant system; and 3D bioprinting applications serving patients internationally. Medprin Regenerative Medical Technologies Co., Ltd. was founded in 2008 and is headquartered in Guangzhou, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.